Loading data for OSRHW — first visit, this takes a few seconds.
OSR Health, Inc. (OSRHW)
NasdaqCM: OSRHW
· Real-Time Price · USD
0.03
+0.00 (0.00%)
At close: Aug 25, 2026, 2:56 PM
The price, the headline numbers and the latest news, in one place.
OSR Health, Inc. (OSRHW) Stock Price, Analysis & Data
No data available
| Bid | 0.08 |
| Market Cap | n/a |
| Revenue (ttm) | 1.81M |
| Net Income (ttm) | -10.7M |
| 0.56 | |
| n/a | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.01 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 0.06 |
| Volume | 21,220 |
| Avg. Volume (20D) | n/a |
| Open | 0.04 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OSRHW
OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antig...
IPO Date Jul 17, 2026
Employees 22
Stock Exchange NasdaqCM
Ticker Symbol OSRHW
Website https://osr-holdings.com
Financial Performance
In 2025, OSR Health's revenue was 2.91M, a decrease of -17.69% compared to the previous year's 3.53M. Earnings were -18.01M, an increase of 74.37%.
Financial StatementsEarnings Surprise
OSR Health has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.